Abstract
The quantity and quality of hair are closely related to the nutritional state of an individual. In instances of protein and calorie malnutrition, deficiency of essential amino acids, of trace elements, and of vitamins, hair growth and pigmentation may be perturbed. The effects of nutrition on hair growth and pigmentation have been recognized from observations in rare inborn errors of metabolism of copper (Menkes kinky hair syndrome), zinc (acrodermatitis enteropathica), biotin (biotinidase and holocarboxylase synthetase deficiency), and amino acids (homocystinuria, Hartnup disease, phenylketonuria, and methionine malabsorption syndrome), in specific acquired deficiency disorders, and from the respective supplementation studies. All vitamins were identified by 1948, ushering in a half century of discovery focused on single-nutrient-deficiency diseases. The first half of the twentieth century witnessed the identification and synthesis of many of the known essential vitamins and minerals and their use to prevent and treat nutritional deficiency-related diseases, specifically protein-calorie malnutrition, deficiencies of biotin, vitamin C, vitamin B12, niacin, essential fatty acids, iron, zinc, copper, selenium, and vitamin D. Accelerating economic development and modernization of agricultural, food processing, and food formulation techniques continued to reduce single-nutrient-deficiency diseases globally. In response, nutrition science shifted to the research on the role of nutrition in more complex conditions, such as gluten sensitivity, obesity, bariatric surgery, anorexia and bulimia, alcoholism, aging, and the oncologic patient. Additional complexity may arise in nutritional recommendations for general well-being versus treatment of specific conditions. Recognition of complexity is a key lesson of the past. Initial observations lead to reasonable, simplified theories that achieve certain practical benefits, which are then inevitably advanced by new knowledge and recognition of ever-increasing complexity.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Androutsos G, Karamanou M, Stefanadis C. William Harvey (1578-1657): discoverer of blood circulation. Hellenic J Cardiol. 2012;53:6–9.
Dronamraju K. Profiles in genetics: Archibald E. Garrod (1857-1936). Am J Hum Genet. 1992;1992(5):216–9.
Menkes JH, Alter M, Steigleder GK, Weakley DR, Sung JH. A sex-linked recessive disorder with retardation of growth, peculiar hair, and focal cerebral and cerebellar degeneration. Pediatrics. 1962;29:764–79.
de Bie P, Muller P, Wijmenga C, Klomp LW. Molecular pathogenesis of Wilson and Menkes disease: correlation of mutations with molecular defects and disease phenotypes. J Med Genet. 2007;44:673–88.
Ivo S, Ralf D, Mercer Julian FB. Chapter 11. Copper: effects of deficiency and overload. In: Sigel A, Sigel H, Sigel RKO, editors. Interrelations between essential metal ions and human diseases. Metal ions in life sciences, vol. 13. Dordrecht: Springer; 2013. p. 359–87.
Kaler SG, Gallo LK, Proud VK, Percy AK, Mark Y, Segal NA, Goldstein DS, Holmes CS, Gahl WA. Occipital horn syndrome and a mild Menkes phenotype associated with splice site mutations at the MNK locus. Nat Genet. 1994;8:195–202.
Tønnesen T, Kleijer WJ, Horn N. Incidence of Menkes disease. Hum Genet. 1991;86:408–10.
Kaler SG, Holmes CS, Goldstein DS. Neonatal diagnosis and treatment of Menkes disease. N Engl J Med. 2008;358:605–14.
Moore CM, Howell RR. Ectodermal manifestations in Menkes disease. Clin Genet. 1985;28:532–40.
Kumar V, Abbas AK, Fausto N. Robbins & Cotran. Pathologic basis of disease. 7th ed. Philadelphia: Elsevier; 2008. p. 16.
Lapointe M. Iron supplementation in the intensive care unit: when, how much, and by what route? Crit Care. 2004;8:S37–41.
Merle U, Schaefer M, Ferenci P, Stremmel W. Clinical presentation, diagnosis and long-term outcome of Wilson’s disease: a cohort study. Gut. 2007;56:115–20.
Ala A, Walker AP, Ashkan K, Dooley JS, Schilsky ML. Wilson’s disease. Lancet. 2007;369:397–408.
Roberts EA, Schilsky ML. A practice guideline on Wilson disease. Hepatology. 2003;37:1475–92.
Kuruvilla A, Joseph S. Face of the giant panda sign in Wilson’s disease: revisited. Neurol India. 2000;48:395–6.
Talhout R, Schulz T, Florek E, Van Benthem J, Wester P, Opperhuizen A. Hazardous compounds in tobacco smoke. Int J Environ Res Public Health. 2011;8:613–28.
Bernhard D, Rossmann A, Wick G. Metals in cigarette smoke. IUBMB Life. 2005;57:805–9.
Sehgal VN, Jain S. Acrodermatitis enteropathica. Clin Dermatol. 2000;18:745–8.
Kasana S, Din J, Maret W. Genetic causes and gene–nutrient interactions in mammalian zinc deficiencies: acrodermatitis enteropathica and transient neonatal zinc deficiency as examples. J Trace Elem Med Biol. 2015;29:47–62.
Ciampo IRLD, Sawamura R, Ciampo LAD, Fernandes MIM. Acrodermatitis enteropathica: clinical manifestations and pediatric diagnosis. Rev Paul Pediatr. 2018;36:238–41.
Ranugha P, Sethi P, Shastry V. Acrodermatitis enteropathica: the need for sustained high dose zinc supplementation. Dermatol Online J. 2018;24:12.
Secor McVoy JRS, Levy HL, Lawler M, Schmidt MA, Ebers DD, Hart S, Pettit DD, Blitzer MG, Wolf B. Partial biotinidase deficiency: clinical and biochemical features. J Pediatr. 1990;116:78–83.
Wolf B, Norrgard K, Pomponio RJ, Mock DM, Secor Mcvoy JR, Fleischhauer K, Shapiro S, Blitzer MG, Hymes J. Profound biotinidase deficiency in two asymptomatic adults. Am J Med Genet. 1997;73:5–9.
Forman DT, Bankson DD, Highsmith WE Jr. Neonatal screening for biotinidase deficiency. Ann Clin Lab Sci. 1992;22:144–54.
Porta F, Pagliardini V, Celestino I, Pavanello E, Pagliardini S, Guardamagna O, Ponzone A, Spada M. Neonatal screening for biotinidase deficiency: a 30-year single center experience. Mol Genet Metab Rep. 2017;13:80–2.
Wolf B. Worldwide survey of neonatal screening for biotinidase deficiency. J Inherit Metab Dis. 1991;14:923–7.
Michalski AJ, Berry GT, Segal S. Holocarboxylase synthetase deficiency: 9-year follow-up of a patient on chronic biotin therapy and a review of the literature. J Inherit Metab Dis. 1989;12:312–6.
McCoy RH, Meyer CE, Rose WC. Feeding experiments with mixtures of highly purified amino acids. VIII. Isolation and identification of a new essential amino acid. J Biol Chem. 1935;112:283–302.
Holtcamp W. The emerging science of BMAA: do cyanobacteria contribute to neurodegenerative disease? Environ Health Perspect. 2012;120:A110–6.
Cox PA, Davis DA, Mash DC, Metcalf JS, Banack SA. Dietary exposure to an environmental toxin triggers neurofibrillary tangles and amyloid deposits in the brain. Proc Biol Sci. 2016;283(1823):20152397.
Holtcamp W. Shark fin consumption may expose people to neurotoxic BMAA. Environ Health Perspect. 2012;120:A191.
Wiest LG, Lutz P, Jung EG, Paweletz N. Morphological and biochemical investigations of hairs in inborn errors of amino acid metabolism (author’s transl). Arch Dermatol Res. 1976;256:53–65.
Morris AA, Kožich V, Santra S, Andria G, Ben-Omran TI, Chakrapani AB, Crushell E, Henderson MJ, Hochuli M, Huemer M, Janssen MC, Maillot F, Mayne PD, McNulty J, Morrison TM, Ogier H, O’Sullivan S, Pavlíková M, de Almeida IT, Terry A, Yap S, Blom HJ, Chapman KA. Guidelines for the diagnosis and management of cystathionine beta-synthase deficiency. J Inherit Metab Dis. 2017;40:49–74.
Cavka M, Kelava T. Homocystinuria, a possible solution of the Akhenaten’s mystery. Coll Antropol. 2010;34:255–8.
Freud S. The standard edition of the complete psychological works of sigmund Freud, volume XXIII (1937–1939), “Moses and monotheism”. London: Hogarth Press; 1964.
Dever WG. What remains of the house that Albright built? In: Wright GE, Cross FM, Campbell EF, Filson FV, editors. The biblical archaeologist, American Schools of Oriental Research, vol. 56: Scholars Press; 1993. p. 25–35, No. 1, p. 33.
Dever WG. What did the biblical writers know and when did they know it? What archeology can tell us about the reality of ancient Israel. Michigan: WM. B. Eerdmans Publishing; 2001. p. 99. ISBN: 978-0-8028-2126-3.
Barber GW, Spaeth GL. The successful treatment of homocystinuria with pyridoxine. J Pediatr. 1969;75:463–78.
Valayannopoulos V, Schiff M, Guffon N, Nadjar Y, García-Cazorla A, Martinez-Pardo Casanova M, Cano A, Couce ML, Dalmau J, Peña-Quintana L, Rigalleau V, Touati G, Aldamiz-Echevarria L, Cathebras P, Eyer D, Brunet D, Damaj L, Dobbelaere D, Gay C, Hiéronimus S, Levrat V, Maillot F. Betaine anhydrous in homocystinuria: results from the RoCH registry. Orphanet J Rare Dis. 2019;4:66.
Milne MD, Crawford MA, Girao CB, Loughridge L. The metabolic disorder of the Hartnup disease. Q J Med. 1961;29:407–21.
Gounelle H, Mitrovic M, Demarne M. On the vitamin B complex content of the hair of normal and pellagrous subjects. Am J Clin Nutr. 1961;9:746–51.
Snyderman SE. The dietary therapy of inherited metabolic disease. Prog Food Nutr Sci. 1975;1:507–30.
Gonzalez J, Willis MS. Ivar Asbjörn Følling. Lab Med. 2010;41:118–9.
Macleod EL, Ney DM. Nutritional management of phenylketonuria. Ann Nestle Eng. 2010;68:58–69.
Michals-Matalon K. Sapropterin dihydrochloride, 6-R-L-erythro-5,6,7,8-tetrahydrobiopterin, in the treatment of phenylketonuria. Expert Opin Investig Drugs. 2008;17:245–51.
Mitchell JJ, Trakadis YJ, Scriver CR. Phenylalanine hydroxylase deficiency. Genet Med. 2011;13:697–707.
Buck PS. The child who never grew. New York: John Day; 1950.
Smith AJ, Strang LB. An inborn error of metabolism with the urinary excretion of alpha-hydroxy-butyric acid and phenylpyruvic acid. Arch Dis Child. 1958;33:109–13.
Chayet NL. Absorption of amino acids. N Engl J Med. 1965;273:560–1.
Bonafe JL, Pieraggi MT, Abravanel M, Benque A, Abravanel G. Skin, hair and nail changes in a case of citrullinemia with late manifestation. Dermatologica. 1984;168:213–8.
Patel HP, Unis ME. Pili torti in association with citrullinemia and arginine succinic aciduria. J Am Acad Dermatol. 1985;12(1 Pt 2):203–6.
Phillips ME, Barrie H, Cream JJ. Argininosuccinic aciduria with pili torti. J R Soc Med. 1981;74:221–2.
Yazaki M, Hineno A, Matsushima A, Ozawa K, Kishida D, Tazawa K, Fukushima K, Urata K, Ikegami T, Miyagawa S, Ikeda S. First two cases of adult-onset type II citrullinemia successfully treated by deceased-donor liver transplantation in Japan. Hepatol Res. 2012;42:934–9.
Shelley WB, Rawnsley HM. Aminogenic alopecia. Loss of hair associated with argininosuccinic aciduria. Lancet. 1965;2:1327–8.
Bachmann C. Long-term outcome of patients with urea cycle disorders and the question of neonatal screening. Eur J Pediatr. 2003;162:S29–33.
Liu T, Howard RM, Mancini AJ, Weston WL, Paller AS, Drolet BA, Esterly NB, Levy ML, et al. Kwashiorkor in the United States: fad diets, perceived and true milk allergy, and nutritional ignorance. Arch Dermatol. 2001;137:630–6.
Badaloo AV, Forrester T, Reid M, Jahoor F. Lipid kinetic differences between children with kwashiorkor and those with marasmus. Am J Clin Nutr. 2006;83:1283–8.
Williams CD, Oxon BM, Lond H. Kwashiorkor: a nutritional disease of children associated with a maize diet. Bull World Health Organ. 1935;81:912–3.
Stanton J. Listening to the Ga: Cicely Williams’ discovery of kwashiorkor on the Gold Coast. Clio Med. 2001;61:149–71.
McLaren DS. Skin in protein energy malnutrition. Arch Dermatol. 1987;123:1674–1676a.
Sims RT. Hair growth in kwashiorkor. Arch Dis Child. 1967;42:397–400.
Wyness LA, McNeill G, Prescott GJ. Trichotillometry: the reliability and practicality of hair pluckability as a method of nutritional assessment. Nutr J. 2007;6:9.
Johnson AA, Latham MC, Roe DA. An evaluation of the use of changes in hair root morphology in the assessment of protein-calorie malnutrition. Am J Clin Nutr. 1976;29:502–11.
Bradfield RB. Hair tissue as a medium for the differential diagnosis of protein-calorie malnutrition: a commentary. J Pediatr. 1974;84:294–6.
Williams CD. Fifty years ago. Archives of diseases in childhood 1933. A nutritional disease of childhood associated with a maize diet. Arch Dis Child. 1983;58:550–60.
No authors listed. Kwashiorkor. A nutritional disease of children associated with a maize diet by Cicely D. Williams from the Lancet, Nov. 16, 1935, p. 1151. Nutr Rev 1973;31:350–1.
Konotey-Ahulu, Felix. There is nothing mysterious about kwashiorkor. Br Med J 2005. Accessed 28 July 2012
Müller O, Krawinkel M. Malnutrition and health in developing countries. Can Med Assoc J. 2005;173:279–86.
Bradfield RB. Hair tissue in the diagnosis of marasmus and kwashiorkor. J Am Med Womens Assoc. 1973;28:393–4.
Steinbart JW. Intermediary forms of malnutrition between kwashiorkor and marasmus [article in German]. Monatsschr Kinderheilkd. 1975;123:285–7.
Bergstrom S, Danielson H, Klenberg D, Samuelsson B. The enzymatic conversion of essential fatty acids into prostaglandins. J Biol Chem. 1964;239:PC4006–8.
Lands WE. Biochemistry and physiology of n-3 fatty acids. FASEB J. 1992;6:2530–6.
Kuda O. Bioactive metabolites of docosahexaenoic acid (Review). Biochimie. 2017;136:12–20.
Truchetet E, Brändle I, Grosshans E. Skin changes, pathophysiology and therapy in deficiency of essential fatty acids. Z Hautkr. 1988;63:290–301.
Schroeter AL, Tucker SB. Essential fatty acid deficiency. Arch Dermatol. 1978;114:800–1.
Burns-Whitmore B, Froyen E, Heskey C, Parker T, San PG. Alpha-linolenic and linoleic fatty acids in the vegan diet: do they require dietary reference intake/adequate intake special consideration? Nutrients. 2019;11:2365.
Le Floc’h C, Cheniti A, Connétable C, Piccardi N, Vincenzi C, Tosti A. Effect of a nutritional supplement on hair loss in women. J Cosmet Dermatol. 2015;14:76–82.
Floersheim GL. Treatment of brittle fingernails with biotin. Z Hautkr. 1989;64:41–8.
Colombo VE, Gerber F, Bronhofer M, Floersheim GL. Treatment of brittle fingernails and onychoschizia with biotin: scanning electron microscopy. J Am Acad Dermatol. 1990;23:1127–32.
Hochman LG, Scher RK, Meyerson MS. Brittle nails: response to daily biotin supplementation. Cutis. 1993;51:303–5.
Iorizzo M, Pazzaglia M, Piraccini B, Tullo S, Tosti A. Brittle nails. J Cosmet Dermatol. 2004;3:138–4.
Floersheim GL. Prüfung der Wirkung von Biotin auf Haarausfall und Haarqualität. Z Hautkr. 1991;67:246–55.
Patel DP, Swink SM, Castelo-Soccio L. A review of the use of biotin for hair loss. Skin Appendage Disord. 2017;3:166–9.
Piraccini BM, Berardesca E, Fabbrocini G, Micali G, Tosti A. Biotin: overview of the treatment of diseases of cutaneous appendages and of hyperseborrhea. G Ital Dermatol Venereol. 2019;154:557–66.
Shelley WB, Shelley ED. Uncombable hair syndrome: observations on response to biotin and occurrence in siblings with ectodermal dysplasia. J Am Acad Dermatol. 1985;13:97–102.
Limat A, Suormala T, Hunziker T, Waelti ER, Braathen LR, Baumgartner R. Proliferation and differentiation of cultured human follicular keratinocytes are not influenced by biotin. Arch Dermatol Res. 1996;288:31–8.
Prendiville JS, Manfredi LN. Skin signs of nutritional disorders. Semin Dermatol. 1992;11:88–97.
György P, Rose CS, Eakin RE, Snell EE, Williams RJ. Egg-white injury as the result of non-absorption or inactivation of biotin. Science. 1941;93:477–8.
Subramanya SB, Subramanian VS, Kumar JS, Hoiness R, Said HM. Inhibition of intestinal biotin absorption by chronic alcohol feeding: cellular and molecular mechanisms. Am J Physiol Gastrointest Liver Physiol. 2011;300:G494–501.
Sealey WM, Teague AM, Stratton SL, Mock DM. Smoking accelerates biotin catabolism in women. Am J Clin Nutr. 2004;80:932–5.
Mock DM, Baswell DL, Baker H, Holman RT, Sweetman L. Biotin deficiency complicating parenteral alimentation: diagnosis, metabolic repercussions, and treatment. J Pediatr. 1985;106:762–9.
Greenway FL, Ingram DK, Ravussin E, Hausmann M, Smith SR, Cox L, Tomayko K, Treadwell BV. Loss of taste responds to high-dose biotin treatment. J Am Coll Nutr. 2011;30:178–81.
Mock DM, Dyken ME. Biotin catabolism is accelerated in adults receiving long-term therapy with anticonvulsants. Neurology. 1997;49:1444–7.
Schulpis KH, Karikas GA, Tjamouranis J, Regoutas S, Tsakiris S. Low serum biotinidase activity in children with valproic acid monotherapy. Epilepsia. 2001;42:1359–62.
Schulpis KH, Georgala S, Papakonstantinou ED, Michas T, Karikas GA. The effect of isotretinoin on biotinidase activity. Skin Pharmacol Appl Skin Physiol. 1999;12:28–33.
Mock DM, Quirk JG, Mock NI. Marginal biotin deficiency during normal pregnancy. Am J Clin Nutr. 2002;75:295–9.
Mock DM. Skin manifestations of biotin deficiency. Semin Dermatol. 1991;10:296–302.
Coulter DL, Beals TF, Allen RJ. Neurotrichosis: hair-shaft abnormalities associated with neurological diseases. Dev Med Child Neurol. 1982;24:634–44.
Seymons K, De Moor A, De Raeve H, Lambert J. Dermatologic signs of biotin deficiency leading to the diagnosis of multiple carboxylase deficiency. Pediatr Dermatol. 2004;21:231–5.
Trüeb RM. Serum biotin levels in women complaining of hair loss. Int J Trichology. 2016;8:73–7.
Said HM. Biotin: biochemical, physiological and clinical aspects. Subcell Biochem. 2012;56:1–19.
Clevidence BA, Marshall MW, Canary JJ. Biotin levels in plasma and urine of heathy adults consuming physiological doses of biotin. Nutr Res. 1988;8:1109–18.
Bitsch RSI, Hötzel D. Studies on bioavailability of oral biotin doses for humans. Int J Vit Nutr Res. 1989;59:65–71.
Zempleni JM, Mock DM. Bioavailability of biotin given orally to humans in pharmacologic doses. Am J Clin Nutr. 1999;69:504–8.
Stone I. On the genetic etiology of scurvy. Acta Genet Med Gemellol (Roma). 1966;15:345–50.
Lind J. A treatise on the scurvy. 3rd ed. G. Pearch and W. Woodfall: London, England; 1772.
Ashhurst J, editor. The international encyclopedia of surgery, vol. 1. New York, NY: William Wood and Co.; 1881. p. 278.
Toler PD. Mankind: the story of all of us. Philadelphia: Running Press; 2012. p. 296. ISBN: 978-0762447176
Milne I. Who was James Lind, and what exactly did he achieve. J R Soc Med. 2012;105:503–8.
Renzaho AMN. Globalisation, migration and health: challenges and opportunities: World Scientific; 2016. p. 94. ISBN: 978-1-78326-889-4
Hürlimann R, Salomon F. Scurvy—a mistakenly forgotten disease [article in German]. Schweiz Med Wochenschr. 1994;124:1373–80.
Agarwal A, Shaharya A, Kumar A, Bhat MS, Mishra M. Scurvy in pediatric age group—a disease often forgotten? J Clin Orthop Trauma. 2015;6:101–7.
Fuchs J. Vitamins and skin [article in German]. Ther Umsch. 1994;51:489–95.
Lessing JN, LaMotte ED, Moshiri AS, Mark NM. Perifollicular haemorrhage with corkscrew hair due to scurvy. Postgrad Med J. 2015;91:719–20.
Hunt A, Harrington D, Robinson S. Vitamin B12 deficiency. BMJ. 2014;349:g5226.
Pawlak R, Parrott SJ, Raj S, Cullum-Dugan D, Lucus D. How prevalent is vitamin B(12) deficiency among vegetarians? Nutr Rev. 2013;71:110–7.
Miller JW. Proton pump inhibitors, H2-receptor antagonists, metformin, and vitamin B-12 deficiency: clinical implications. Adv Nutr (Bethesda, MD). 2018;9:511S–8S.
Wang H, Li L, Qin LL, Song Y, Vidal-Alaball V, Liu TH. Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency. Cochrane Database Syst Rev. 2018;3:CD004655.
Hunt A, Harrington D, Robinson S. Vitamin B12 deficiency. BMJ. 2014;349:g5226.
Herrmann W, Obeid R. Causes and early diagnosis of vitamin B12 deficiency. Deutsches Arzteblatt international. 2008;105:680–5.
Jarquin Campos A, Risch L, Nydegger U, Wiesner J, Vazquez Van Dyck M, Renz H, Stanga Z, Risch M. Diagnostic accuracy of holotranscobalamin, vitamin B12, methylmalonic acid, and homocysteine in detecting B12 deficiency in a large, mixed patient population. Dis Markers. 2020;2020:7468506.
Dietary Supplement Fact Sheet: Vitamin B12—Health Professional Fact Sheet. National Institutes of Health: Office of Dietary Supplements. 2016-02-11. Archived from the original on 2016-07-27. Accessed 15 July 2016.
Sonthalia S, Priya A, Tobin DJ. Demographic characteristics and association of serum vitamin B12, ferritin and thyroid function with premature canities in indian patients from an urban skin clinic of North India: a retrospective analysis of 71 cases. Indian J Dermatol. 2017;62:304–8.
Capo A, Amerio P. Polyglandular autoimmune syndrome type III with a prevalence of cutaneous features. Clin Exp Dermatol. 2017;42:61–3.
Kumar B, Sharma VK, Sehgal S. Antismooth muscle and antiparietal cell antibodies in Indians with alopecia areata. Int J Dermatol. 1995;34:542–5.
Daly T, Daly K. Telogen effluvium with dysesthesia (TED) has lower B12 levels and may respond to B12 supplementation. J Drugs Dermatol. 2018;17:1236–40.
Devalia V, Hamilton MS, Molloy AM. Guidelines for the diagnosis and treatment of cobalamin and folate disorders. Br J Haematol. 2014;166:496–513.
Holm RP. The corn-skin connection. S D Med. 2009;62:449.
Portale S, Sculati M, Stanford FC, Cena H. Pellagra and anorexia nervosa: a case report. Eat Weight Disord. 2019; https://doi.org/10.1007/s40519-019-00781-x. [Epub ahead of print]
Zaki I, Millard L. Pellagra complicating Crohn’s disease. Postgrad Med J. 1995;71:496–7.
Bilgili SG, Karadag AS, Calka O, Altun F. Isoniazid-induced pellagra. Cutan Ocul Toxicol. 2011;30:317–9.
Bell HK, Poston GJ, Vora J, Wilson NJ. Cutaneous manifestations of the malignant carcinoid syndrome. Br J Dermatol. 2005;152:71–5.
Creamer D. Malnutrition and skin disease in Far East prisoners-of-war in World War II. Clin Exp Dermatol. 2018;43:766–9.
Chaidemenos GC, Mourellou O, Karakatsanis G, Koussidou T, Xenidis E, Charalampidou H, Avgoloupis D. Acute hemorrhagic pellagra in an Albanian refugee. Cutis. 2002;69:96–8.
Licata M, Iorio S. What disease did Goethe witness during his journey through the Italian Alps? Was it pellagra or another disease of malnutrition? Nutr Diet. 2018;75:541.
Williams AC, Hill LJ. The 4 D’s of pellagra and progress. Int J Tryptophan Res. 2020;13:1178646920910159.
Hegyi J, Schwartz RA, Hegyi V. Pellagra: dermatitis, dementia, and diarrhea. Int J Dermatol. 2004;43:1–5.
Spivak JL, Jackson DL. Pellagra: an analysis of 18 patients and a review of the literature. Johns Hopkins Med J. 1977;140:295–309.
World Health Organization (2009). In: Stuart MC, Kouimtzi M, Hill SR (editors). WHO Model Formulary 2008. World Health Organization, pp. 496, 500
Centers for Disease Control (CDC). Iron deficiency–United States, 1999–2000. Morb Mortal Wkly Rep. 2002;51:897–9.
Hard S. Non-anemic iron deficiency as an etiologic factor in diffuse loss of hair of the scalp in women. Acta Derm Venereol. 1963;43:562–9.
Aguilera MC. Diffuse alopecia in women and hyposideremia [article in Spanish]. Actas Dermosifiliogr. 1966;57:169–80.
Rushton DH, Ramsay ID, James KC, Norris MJ, Gilkes JJ. Biochemical and trichological characterization of diffuse alopecia in women. Br J Dermatol. 1990;123:187–97.
Aydingoz I, Ferhanoglu B, Guney O. Does tissue iron status have a role in female alopecia? J Eur Acad Dermatol Venereol. 1999;13:65–7.
Sinclair R. There is no clear association between low serum ferritin and chronic diffuse telogen hair loss. Br J Dermatol. 2002;147:982–4.
Kantor J, Kessler LJ, Brooks DG, Cotsarelis G. Decreased serum ferritin is associated with alopecia in women. J Invest Dermatol. 2003;121:985–8.
Chamberlain AJ, Dawber RP. Significance of iron status in hair loss in women. Br J Dermatol. 2003;149:428.
Rushton DH. Decreased serum ferritin and alopecia in women. J Invest Dermatol. 2003;121:xvii–xviii.
Trost LB, Bergfeld WF, Calogeras E. The diagnosis and treatment of iron deficiency and its potential relationship to hair loss. J Am Acad Dermatol. 2006;54:824–44.
Deloche C, Bastien P, Chadoutaud S, Galan P, Bertrais S, Hercberg S, de Lacharrière O. Low iron stores: a risk factor for excessive hair loss in non-menopausal women. Eur J Dermatol. 2007;17:507–12.
Moeinvaziri M, Mansoori P, Holakooee K, Safaee Naraghi Z, Abbasi A. Iron status in diffuse telogen hair loss among women. Acta Dermatovenerol Croat. 2009;17:279–84.
Olsen EA, Reed KB, Cacchio PB, Caudill L. Iron deficiency in female pattern hair loss, chronic telogen effluvium, and control groups. J Am Acad Dermatol. 2010;63:991–9.
St Pierre SA, Vercellotti GM, Donovan JC, Hordinsky MK. Iron deficiency and diffuse nonscarring scalp alopecia in women: more pieces to the puzzle. J Am Acad Dermatol. 2010;63:1070–6.
Wang W, Knovich MA, Coffman LG, Torti FM, Torti SV. Serum ferritin: past, present and future. Biochim Biophys Acta. 2010;1800:760–9.
Firkin F, Rush B. Interpretation of biochemical tests for iron deficiency: diagnostic difficulties related to limitations of individual tests. Aust Prescr. 1997;20:74–6.
Waalen J, Felitti V, Beutler E. Haemoglobin and ferritin concentrations in men and women: cross sectional study. BMJ. 2002;325:137.
Schrier SL. Causes and diagnosis of anaemia due to iron deficiency. www.UpToDate.com, last updated 6 Nov 2003.
Centers for Disease Control (CDC). Recommendations to prevent and control iron deficiency in the Unites States. Morb Mortal Wkly Rep. 1998;47:1–36.
Bregy A, Trüeb RM. No association between serum ferritin levels >10 microg/l and hair loss activity in women. Dermatology. 2008;217:1–6.
Groopman J. How doctors think. Boston, NY: Houghton Mifflin Company; 2007.
DeLoughery TG. Safety of oral and intravenous iron. Acta Haematol. 2019;142:8–12.
Rampton D, Folkersen J, Fishbane S, Hedenus M, Howaldt S, Locatelli F, Patni S, Szebeni J, Weiss G. Hypersensitivity reactions to intravenous iron: guidance for risk minimization and management. Haematologica. 2014;99:1671–6.
Wong M, Bryson M. Extensive skin hyperpigmentation following intravenous iron infusion. Br J Haematol. 2019;184:709.
Moltz L. Hormonal diagnosis in so-called androgenetic alopecia in the female [Article in German]. Geburtshilfe Frauenheilkd. 1988;48:203–14.
Maret W, Sandstead HH. Zinc requirements and the risks and benefits of zinc supplementation. J Trace Elem Med Biol. 2006;20:3–18.
Prasad AS. Discovery of human zinc deficiency: 50 years later. J Trace Elem Med Biol. 2012;26:66–9.
Solomons NW. Dietary sources of zinc and factors affecting its bioavailability. Food Nutr Bull. 2001;22:138–54.
Prasad AS, Miale A, Farid Z, Sandstead HH, Schulert AR. Zinc metabolism in patients with the syndrome of iron deficiency anemia, hepatosplenomegaly, dwarfism, and hypogonadism. J Lab Clin Med. 1963;61:537–49.
American Dietetic Association. Position of the American Dietetic Association and Dietitians of Canada: vegetarian diets. J Am Diet Assoc. 2003;103:748–65.
Freeland-Graves JH, Bodzy PW, Epright MA. Zinc status of vegetarians. J Am Diet Assoc. 1980;77:655–61.
Smit AJ, Hoorntje SJ, Donker AJ. Zinc deficiency during captopril treatment. Nephron. 1983;34:196–7.
Ikeda M, Ikui A, Komiyama A, Kobayashi D, Tanaka M. Causative factors of taste disorders in the elderly, and therapeutic effects of zinc. J Laryngol Otol. 2008;122:155–60.
Stewart-Knox BJ, Simpson EE, Parr H, Rae G, Polito A, Intorre F, Andriollo Sanchez M, Meunier N, O’Connor JM, Maiani G, Coudray C, Strain JJ. Taste acuity in response to zinc supplementation in older Europeans. Br J Nutr. 2008;99:129–36.
Suzuki H, Asakawa A, Li JB, Tsai M, Amitani H, Ohinata K, Komai M, Inui A. Zinc as an appetite stimulator - the possible role of zinc in the progression of diseases such as cachexia and sarcopenia. Recent Pat Food Nutr Agric. 2011;3:226–31.
Bakan R. The role of zinc in anorexia nervosa: etiology and treatment. Med Hypotheses. 1979;5:731–6.
Birmingham CL, Goldner EM, Bakan R. Controlled trial of zinc supplementation in anorexia nervosa. Int J Eat Disord. 1994;15:251–5.
Alhaj E, Alhaj N, Alhaj NE. Diffuse alopecia in a child due to dietary zinc deficiency. Skinmed. 2007;6:199–200.
Prasad AS. Discovery of human zinc deficiency: its impact on human health and disease. Adv Nutr. 2013;4:176–90.
Hess SY, Peerson JM, King JC, Brown KH. Use of serum zinc concentration as an indicator of population zinc status. Food Nutr Bull. 2007;28(3 Suppl):S403–29.
Arnaud J, Beani JC, Favier AE, Amblard P. Zinc status in patients with telogen defluvium. Acta Derm Venereol. 1995;75:248–9.
Karashima T, Tsuruta D, Hamada T, Ono F, Ishii N, Abe T, Ohyama B, Nakama T, Dainichi T, Hashimoto T. Oral zinc therapy for zinc deficiency-related telogen effluvium. Dermatol Ther. 2012;25:210–3.
Weismann K, Hagdrup HK. Hair changes due to zinc deficiency in a case of sucrose malabsorption. Acta Derm Venereol. 1981;61:444–7.
Dupré A, Bonafé JL, Carriere JP. The hair in acrodermatitis enteropathica—a disease indicator? Acta Derm Venereol. 1979;59:177–8.
Traupe H, Happle R, Gröbe H, Bertram HP. Polarization microscopy of hair in acrodermatitis enteropathica. Pediatr Dermatol. 1986;3:300–3.
Slonim AE, Sadick N, Pugliese M, Meyers-Seifer CH. Clinical response of alopecia, trichorrhexis nodosa, and dry, scaly skin to zinc supplementation. J Pediatr. 1992;121:890–5.
Wolowa F, Jablonska S. Zinc in the treatment of alopecia areata. In: Kobori T, Montagna W, Toda K, editors. Biology and disease of the hair. 2nd ed. Tokyo: University of Tokyo Press; 1976. p. 305–8.
Camacho FM, Garcia-Hernandez MJ. Zinc aspartate, biotin, and clobetasol propionate in the treatment of alopecia areata in childhood. Pediatr Dermatol. 1999;16:336–8.
Ead RD. Oral zinc sulphate in alopecia areata-a double blind trial. Br J Dermatol. 1981;104:483–4.
Lee SY, Nam KS, Seo YW, Lee JS, Chung H. Analysis of serum zinc and copper levels in alopecia areata. Ann Dermatol. 1997;9:239–41.
Malanin K, Telegdy E, Qazaq H. Hair loss and serum zinc values among Arab females in Al Ain region, United Arab Emirates. Eur J Dermatol. 2007;17:446–7.
Mussalo-Rauhamaa H, Lakomaa EL, Kianto U, Lehto J. Element concentrations in serum, erythrocytes, hair and urine of alopecia patients. Acta Derm Venereol. 1986;66:103–9.
Park H, Kim CW, Kim SS, Park CW. The therapeutic effect and the changed serum zinc level after zinc supplementation in alopecia areata patients who had a low serum zinc level. Ann Dermatol. 2009;21:142–6.
Baltaci AK, Mogulkoc R, Baltaci SB. Review: the role of zinc in the endocrine system. Pak J Pharm Sci. 2019;32:231–9.
Jaiser SR, Winston GP. Copper deficiency myelopathy. [Review]. J Neurol. 2010;257:869–81.
Handeland K, Bernhoft A, Aartun MS. A copper deficiency and effects of copper supplementation in a herd of Red Deer (Cervus Elaphus). Acta Vet Scand. 2008;50:8.
Jaiser SR, Winston GP. Copper deficiency myelopathy [Review]. J Neurol. 2010;257:869–81.
Kumar N. Copper deficiency myelopathy (human swayback). Mayo Clin Proc. 2006;81:1371–84.
Hedera P, Peltier A, Fink JK, Wilcock S, London Z, Brewer GJ. Myelopolyneuropathy and pancytopenia due to copper deficiency and high zinc levels of unknown origin II. The denture cream is a primary source of excessive zinc. Neurotoxicology (Amsterdam). 2009;30:996–9.
Schleper B, Stuerenburg HJ. Copper deficiency-associated myelopathy in a 46-year-old woman. J Neurol. 2001;248:705–6.
Goodman JC. Neurological complications of bariatric surgery. Curr Neurol Neurosci Rep. 2015;15:79.
Maksimović J, Djujić I, Jović V, Rsumović M. A selenium deficiency in Yugoslavia. Biol Trace Elem Res. 1992;33:187–96.
Ngigi PB, Du Laing G, Masinde PW, Lachat C. Selenium deficiency risk in central Kenya highlands: an assessment from the soil to the body. Environ Geochem Health. 2019; https://doi.org/10.1007/s10653-019-00494-1. Online ahead of print.
Var P, Alfihan G, Ekholm P, Aro A, Koivistoinen P. Selenium intake and serum selenium in Finland: effects of soil fertilization with selenium. Am J Clin Nutr. 1988;48:324–9.
Beck MA, Levander OA, Handy J. Selenium deficiency and viral infection. J Nutr. 2003;133:1463S–7S.
Moreno-Reyes R, Carl S, Mathieu F, Begaux F, Zhu D, Rivera MT, Boelaer M, Nève J, et al. Kashin–Beck osteoarthropathy in rural tibet in relation to selenium and iodine status. N Engl J Med. 1998;339:1112–20.
Yao PF, Kang P. Selenium, iodine, and the relation with Kashin–Beck disease. Nutrition. 2011;27:1095–100.
Ravaglia G, Forti P, Maioli F, Bastagli L, Facchini A, Mariani E, Savarino L, Sassi S, et al. Effect of micronutrient status on natural killer cell immune function in healthy free-living subjects aged ≥90 y. Am J Clin Nutr. 2000;71:590–8.
Kanekura T, Yotsumoto S, Maeno N, Kamenosono A, Saruwatari H, Uchino Y, Mera Y, Kanzaki T. Selenium deficiency: report of a case. Clin Exp Dermatol. 2005;30:346–8.
Pittas AG, Chung M, Trikalinos T, Mitri J, Brendel M, Patel K, Lichtenstein AH, Lau J, Balk EM. Systematic review: vitamin D and cardiometabolic outcomes. Ann Intern Med. 2010;152:307–14.
Chung M, Balk EM, Brendel M, Ip S, Lau J, Lee J, Lichtenstein A, Patel K, Raman G, Tatsioni A, Terasawa T, Trikalinos TA. Vitamin D and calcium: a systematic review of health outcomes. Evid Rep Technol Assess. 2009;183:1–420.
Bjelakovic G, Gluud LL, Nikolova D, Whitfield K, Wetterslev J, Simonetti RG, Bjelakovic M, Gluud C. Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev. 2014;1:CD007470.
Bolland MJ, Grey A, Gamble GD, Reid IR. The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysis. Lancet Diabet& Endocrinol. 2014;2:307–20.
Tamura M, Ishizawa M, Isojima T, Özen S, Oka A, Makishima M, Kitanaka S. Functional analyses of a novel missense and other mutations of the vitamin D receptor in association with alopecia. Sci Rep. 2017;7:5102.
Xie Z, Komuves L, Yu Q-C, Elalieh H, Ng DC, Leary C, et al. Lack of the vitamin D receptor is associated with reduced epidermal differentiation and hair follicle growth. J Invest Dermatol. 2002;118:11–6.
Amor KT, Rashid RM, Mirmirani P. Does D matter? The role of vitamin D in hair disorders and hair follicle cycling. Dermatol Online J. 2010;16:3.
Fawzi MM, Mahmoud SB, Ahmed SF, Shaker OG. Assessment of vitamin D receptors in alopecia areata and androgenetic alopecia. J Cosmet Dermatol. 2016;15:318–23.
Yilmaz N, Serarslan G, Gokce C. Vitamin D concentration are decreased in patients with alopecia areata. Vitam Trace Elem. 2019;1:105–9.
d’Ovidio R, Vessio M, d’Ovidio FD. Reduced level of 25-hydroxyvitamin D in chronic/relapsing alopecia areata. Dermatoendocrinol. 2013;5:271–3.
Aksu Cerman A, Sarikaya Solak S, Kivanc Altunay I. Vitamin D deficiency in alopecia areata. Br J Dermatol. 2014;170:1299–304.
Mahamid M, Abu-Elhija O, Samamra M, Mahamid A, Nseir W. Association between vitamin D levels and alopecia areata. Isr Med Assoc J. 2014;16:367–70.
Bakry OA, El Farargy SM, El Shafiee MK, Soliman A. Serum Vitamin D in patients with alopecia areata. Indian Dermatol Online J. 2016;7:371–7.
Ghafoor R, Anwar MI. Vitamin D deficiency in alopecia areata. J Coll Physicians Surg Pak. 2017;27:200–2.
Erpolat S, Sarifakioglu E, Ayyildiz A. 25-Hydroxyvitamin D status in patients with alopecia areata. Postepy Dermatol Alergol. 2017;34:248–52.
Unal M, Gonulalan G. Serum vitamin D level is related to disease severity in pediatric alopecia areata. J Cosmet Dermatol. 2018;17:101–4.
Thompson JM, Li T, Park MK, Qureshi AA, Cho E. Estimated serum vitamin D status, vitamin D intake, and risk of incident alopecia areata among US women. Arch Dermatol Res. 2016;308:671–6.
Rasheed H, Mahgoub D, Hegazy R, El-Komy M, Abdel Hay R, Hamid MA, et al. Serum ferritin and vitamin D in female hair loss: do they play a role? Skin Pharmacol Physiol. 2013;26:101–7.
Banihashemi M, Nahidi Y, Meibodi NT, Jarahi L, Dolatkhah M. Serum vitamin D3 level in patients with female pattern hair loss. Int J Trichology. 2016;8:116–20.
Cheung E, Sink J, English Lii J. Vitamin and mineral deficiencies in patients with telogen effluvium: a retrospective cross-sectional study. J Drugs Dermatol. 2016;15(10):1235–7.
Nayak K, Garg A, Mithra P, Manjrekar P. Serum vitamin D3 levels and diffuse hair fall among the student population in south India: a case-control study. Int J Trichology. 2016;8:160–4.
Speicher P. Serum vitamin D levels in women with hair loss. Inaugural Dissertation, University of Zurich, in preparation.
O’Brien KF, Maiman RE, DeWitt CA. Multiple nutritional deficiencies in a morbidly obese patient. Am J Gastroenterol. 2019;114:11.
Argilés JM. Cancer-associated malnutrition. Eur J Oncol Nurs. 2005;9(Suppl 2):S39–50.
Leandro-Merhi VA, Costa CL, Saragiotto L, Aquino JLB. Nutritional indicators of malnutrition in hospitalized patients. Arq Gastroenterol. 2019;56:447–50.
Khor GL. Update on the prevalence of malnutrition among children in Asia. Nepal Med Coll J. 2003;5:113–22.
Aparicio E, Canals J, Pérez S, Arija V. Dietary intake and nutritional risk in Mediterranean adolescents in relation to the severity of the eating disorder. Public Health Nutr. 2015;18:1461–73.
Li S, Ney M, Eslamparast T, Vandermeer B, Ismond KP, Kroeker K, Halloran B, Raman M, Tandon P. Systematic review of nutrition screening and assessment in inflammatory bowel disease. World J Gastroenterol. 2019;25:3823–37.
Mziray-Andrew CH, Sentongo TA. Nutritional deficiencies in intestinal failure. Pediatr Clin North Am. 2009;56:1185–200.
Cano NJ, Heng AE, Pison C. Multimodal approach to malnutrition in malnourished maintenance hemodialysis patients. J Ren Nutr. 2011;21:23–6.
Shaker M, Venter C. The ins and outs of managing avoidance diets for food allergies. Curr Opin Pediatr. 2016;28:567–72.
Redondo Robles L, Pintor de la Maza B, Tejada García J, García Vieitez JJ, Fernández Gómez MJ, Barrera Mellado I, Ballesteros Pomar MD. Nutritional profile of multiple sclerosis. Nutr Hosp. 2019;36:340–9.
Imdad A, Bhutta ZA. Intervention strategies to address multiple micronutrient deficiencies in pregnancy and early childhood. Nestle Nutr Inst Workshop Ser. 2012;70:61–73.
Beck AM. Nutritional interventions among old people receiving support at home. Proc Nutr Soc. 2018;77:265–9.
Park M, Song JA, Lee M, Jeong H, Lim S, Lee H, Kim CG, Kim JS, Kim KS, Lee YW, Lim YM, Park YS, Yoon JC, Kim KW, Hong GS. National study of the nutritional status of Korean older adults with dementia who are living in long-term care settings. Jpn J Nurs Sci. 2018;15:318–29.
Pingleton SK. Nutrition in chronic critical illness. Clin Chest Med. 2001;22:149–63.
Darmon N. A fortified street food to prevent nutritional deficiencies in homeless men in France. J Am Coll Nutr. 2009;28:196–202.
Dickson JM, Naylor G, Colver G, Powers HJ, Masters P. Multiple vitamin deficiencies in a patient with a history of chronic alcohol excess and self-neglect in the UK. BMJ Case Rep. 2014;2014:bcr2014204523.
Kuroda T, Uenishi K, Ohta H, Shiraki M. Multiple vitamin deficiencies additively increase the risk of incident fractures in Japanese postmenopausal women. Osteoporos Int. 2019;30:593–9.
Söderström L, Rosenblad A, Thors Adolfsson E, Bergkvist L. Malnutrition is associated with increased mortality in older adults regardless of the cause of death. Br J Nutr. 2017;117:532–40.
Heath ML, Sidbury R. Cutaneous manifestations of nutritional deficiency. Curr Opin Pediatr. 2006;18:417–22.
Goskowicz M, Eichenfield LF. Cutaneous findings of nutritional deficiencies in children. Curr Opin Pediatr. 1993;5:441–5.
Huber MA, Hall EH. Glossodynia in patients with nutritional deficiencies. Ear Nose Throat J. 1989;68:771–5.
Sapone A, Bai JC, Ciacci C, Dolinsek J, Green PH, Hadjivassiliou M, Kaukinen K, Rostami K, Sanders DS, Schumann M, Ullrich R, Villalta D, Volta U, Catassi C, Fasano A. Spectrum of gluten-related disorders: consensus on new nomenclature and classification. BMC Med. 2012;10:13.
Lebwohl B, Ludvigsson JF, Green PH. Celiac disease and non-celiac gluten sensitivity. BMJ. 2015;351:h4347.
Fasano A. Clinical presentation of celiac disease in the pediatric population. Gastroenterology. 2005;128(4 Suppl 1):S68–73.
Lionetti E, Gatti S, Pulvirenti A, Catassi C. Celiac disease from a global perspective. Best Pract Res Clin Gastroenterol. 2015;29:365–79.
Ludvigsson JF, Card T, Ciclitira PJ, Swift GL, Nasr I, Sanders DS, Ciacci C. Support for patients with celiac disease: a literature review. United Eur Gastroenterol J. 2015;3:146–59.
Lundin KE, Wijmenga C. Coeliac disease and autoimmune disease-genetic overlap and screening. Nat Rev Gastroenterol Hepatol. 2015;12:507–15.
Corazza GR, Andreani ML, Venturo N, et al. Celiac disease and alopecia areata: report of a new association. Gastroenterology. 1995;109(4):1333–7.
Naveh Y, Rosenthal E, Ben-Arieh Y, Etzioni A. Celiac disease-associated alopecia in childhood. J Pediatr. 1999;134:362–4.
Ertekin V, Tosun MS, Erdem T. Screening of celiac disease in children with alopecia areata. Indian J Dermatol. 2014;59(3):317.
Catassi C, Bai JC, Bonaz B, Bouma G, Calabrò A, Carroccio A, Castillejo G, Ciacci C, Cristofori F, Dolinsek J, Francavilla R, Elli L, Green P, Holtmeier W, Koehler P, Koletzko S, Meinhold C, Sanders D, Schumann M, Schuppan D, Ullrich R, Vécsei A, Volta U, Zevallos V, Sapone A, Fasano A. Non-celiac gluten sensitivity: the new frontier of gluten related disorders. Nutrients. 2013;5:3839–53.
Mansueto P, Seidita A, D’Alcamo A, Carroccio A. Non-celiac gluten sensitivity: literature review. J Am Coll Nutr. 2014;33:39–54.
Verdu EF, Armstrong D, Murray JA. Between celiac disease and irritable bowel syndrome: the “no man’s land” of gluten sensitivity. Am J Gastroenterol. 2009;104:1587–94.
van der Windt DA, Jellema P, Mulder CJ, Kneepkens CM, van der Horst HE. Diagnostic testing for celiac disease among patients with abdominal symptoms: a systematic review. JAMA. 2010;303:1738–46.
Lewis NR, Scott BB. Systematic review: the use of serology to exclude or diagnose coeliac disease (a comparison of the endomysial and tissue transglutaminase antibody tests). Aliment Pharmacol Ther. 2006;24:47–54.
Rostom A, Murray JA, Kagnoff MF. American Gastroenterological Association (AGA) Institute technical review on the diagnosis and management of celiac disease. Gastroenterology. 2006;131:1981–2002.
Hill ID, Dirks MH, Liptak GS, Colletti RB, Fasano A, Guandalini S, Hoffenberg EJ, Horvath K, Murray JA, Pivor M, Seidman EG. Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr. 2005;40:1–19.
Bondavalli P, Quadri G, Parodi A, Rebora A. Failure of gluten-free diet in celiac disease-associated alopecia areata. Acta Derm Venereol. 1998;78:319.
Viola F, Barbato M, Formisano M, et al. Reappearance of alopecia areata in a coeliac patient during an unintentional challenge with gluten. Minerva Gastroenterol Dietol. 1999;45:283–5.
Bardella MT, Marino R, Barbareschi M, et al. Alopecia areata and coeliac disease: no effect of a gluten-free diet on hair growth. Dermatology. 2000;200:108–10.
Zampetti M, Filippetti R. Alopecia areata and celiac disease. G Ital Dermatol Venereol. 2008;143(2):168.
Sun X, Lu L, Yang R, Li Y, Shan L, Wang Y. Increased incidence of thyroid disease in patients with celiac disease: a systematic review and meta-analysis. PLoS One. 2016;11:e0168708.
Kanazawa M, Yoshiike N, Osaka T, Numba Y, Zimmet P, Inoue S. Criteria and classification of obesity in Japan and Asia-Oceania. Nutrition and fitness: obesity, the metabolic syndrome, cardiovascular disease, and cancer. World Rev Nutr Diet. 2005;94:1–12.
Zhou BF. Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults—study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Biomed Environ Sci. 2002;15:83–96.
Singh D. Female mate value at a glance: relationship of waist-to-hip ratio to health, fecundity and attractiveness. Neuro Endocrinol Lett. 2002;23(Suppl 4):81–91.
Marlowe F, Apicella C, Reed D. Men’s preferences for women’s profile waist-to-hip ratio in two societies. Evol Hum Behav. 2005;26:458–68.
Cagnacci A, Zanin R, Cannoletta M, Generali M, Caretto S, Volpe A. Menopause, estrogens, progestins, or their combination on body weight and anthropometric measure. Fertil Steril. 2007;88:1603–8.
Freeman EW, Sammel MD, Lin H, Gracia CR. Obesity and reproductive hormone levels in the transition to menopause. Menopause. 2007;17:718–26.
Cagnacci A, Zanin R, Cannoletta M, Generali M, Caretto S, Volpe A. Menopause, estrogens, progestins, or their combination on body weight and anthropometric measure. Fertil Steril. 2007;88:1603–8.
Ogden CL, Carroll MD, Fryar CD, Flegal KM. Prevalence of childhood and adult obesity in the Unites States, 2011-2012. JAMA. 2014;311:806–14.
Vogelezang S, Monnereau C, Gaillard R, Renders CM, Hofman A, Jaddoe VW, Felix JF. Adult adiposity susceptibility loci, early growth and general and abdominal fatness in childhood. The Generation R Study. Int J Obes. 2015;39:1001–9.
Shoelson SE, Herrero L, Naaz A. Obesity, inflammation, and insulin resistance. Gastroenterology. 2007;132:2169–80.
Dentali F, Squizzato A, Ageno W. The metabolic syndrome as a risk factor for venous and arterial thrombosis. Semin Thromb Hemost. 2009;35:451–7.
Pallardo LF, Molina RC. Case of alopecia, in prepuberal obesity syndrome, treated with ACTH. Medicamenta (Madr). 1954;2:121–6.
Malaisse W, Lauvaux JP, Franckson JR, Bastenie PA. Diabetes in bearded women (Achard-Thiers-Syndrome): a clinical and metabolic study of 20 cases. Diabetologia. 1966;1:155–61.
Lubowe I. Achard-Thiers syndrome. Arch Dermatol. 1971;103:544–5.
Gracia-Ramos AE. Morgagni-Stewart-Morel syndrome. Case report and review of the literature. Rev Med Inst Mex Seguro Soc. 2016;54:664–9.
Azziz R, Adashi EY. Stein and Leventhal: 80 years on. Am J Obstet Gynecol. 2016;214:247.e1–247.e11.
Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19:41–7.
Ding T, Hardiman PJ, Petersen I, Wang FF, Qu F, Baio G. The prevalence of polycystic ovary syndrome in reproductive-aged women of different ethnicity: a systematic review and meta-analysis. Oncotarget. 2017;8:96,351–8.
Spritzer PM, Barone CR, Oliveira FB. Hirsutism in polycystic ovary syndrome: pathophysiology and management. Curr Pharm Des. 2016;22:5603–13.
Wong M, Zhao X, Hong Y, Yang D. Semiquantitative assessment of hirsutism in 850 PCOS patients and 2,988 controls in China. Endokrynol Pol. 2014;65(5):365–70.
Franik G, Bizoń A, Włoch S, Kowalczyk K, Biernacka-Bartnik A, Madej P. Hormonal and metabolic aspects of acne vulgaris in women with polycystic ovary syndrome. Eur Rev Med Pharmacol Sci. 2018;22:4411–8.
Vexiau P, Chaspoux C, Boudou P, et al. Effects of minoxidil 2% vs. cyproterone acetate treatment on female androgenetic alopecia: a controlled, 12-month randomized trial. Br J Dermatol. 2002;146:992–9.
Gilbert EW, Tay CT, Hiam DS, Teede HJ, Moran LJ. Comorbidities and complications of polycystic ovary syndrome: an overview of systematic reviews. Clin Endocrinol (Oxf). 2018;89:683–99.
O’Brien B, Dahiya R, Kimble R. Hyperandrogenism, insulin resistance and acanthosis nigricans (HAIR-AN syndrome): an extreme subphenotype of polycystic ovary syndrome. BMJ Case Rep. 2020;1:pii e231749.
Piacquadio DJ, Rad FS, Spellman MC, Hollenbach KA. Obesity and female androgenic alopecia: a cause and an effect? J Am Acad Dermatol. 1994;30:1028–30.
Mirmirani P, Carpenter DM. The impact of obesity on the folliculosebaceous unit. J Am Acad Dermatol. 2014;71:584–5.
Yang CC, Hsieh FN, Lin LY, Hsu CK, Sheu HM, Chen W. Higher body mass index is associated with greater severity of alopecia in men with male-pattern androgenetic alopecia in Taiwan: a cross-sectional study. J Am Acad Dermatol. 2014;70:297–302.
Hirsso P, Rajala U, Hiltunen L, Jokelainen J, Keinänen-Kiukaanniemi S, Näyhä S. Obesity and low-grade inflammation among young Finnish men with early-onset alopecia. Dermatology. 2007;214:125–9.
Arias-Santiago S, Gutiérrez-Salmerón MT, Castellote-Caballero L, Buendía-Eisman A, Naranjo-Sintes. Androgenetic alopecia and cardiovascular risk factors in men and women: a comparative study. J Am Acad Dermatol. 2010;63:420–9.
Starka L, Duskova M, Cermakova I, et al. Premature androgenic alopecia and insulin resistance. Male equivalent of polycystic ovary syndrome? Endocr Regul. 2010;39:127–31.
Lee CN, Chen W, Hsu CK, Weng TT, Lee JY, Yang CC. Dissecting folliculitis (dissecting cellulitis) of the scalp: a 66-patient case series and proposal of classification. J Dtsch Dermatol Ges. 2018;16:1219–26.
Lijesen GK, Theeuwen I, Assendelft WJ, Van Der Wal G. The effect of human chorionic gonadotropin (HCG) in the treatment of obesity by means of the Simeons therapy: a criteria-based meta-analysis. Br J Clin Pharmacol. 1995;40:237–43.
Goette DK, Odum RB. Letter: profuse hair loss. Arch Dermatol. 1975;111:930.
Griggs J, Almohanna H, Ahmed A, Tosti A. New-onset androgenic alopecia following human chorionic gonadotropic diet and testosterone pellet implantation. Int J Trichology. 2018;10:284–5.
Colquitt JL, et al. Surgery for weight loss in adults. Cochrane Database Syst Rev. 2014;8:CD003641.
Stein J, Stier C, Raab H, Weinger R. Review article: the nutritional and pharmacological consequence of obesity surgery. Aliment Pharmacol Ther. 2014;40:582–609.
Faintuch J, Matsuda M, Cruz ME, et al. Severe protein-calorie malnutrition after bariatric procedures. Obes Surg. 2004;14:175–81.
Heber D, Greenway FL, Kaplan LM, Livingston E, .Salvador J, Still C. Endocrine and nutritional management of the post-bariatric surgery patient: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 95:4823-4843 (2010)
Rennie MJ, Bohe J, Smith K, Wackerhage H, Greenhaff P. Branched amino acids as fuels and ababolic sgnals in human muscle. J Nutr. 2006;136:264S–8S.
Janssen I, Fortier A, Hudson R, Ross R. Effects of an energy-restrictive diet with or without exercise on abdominal fat, intermuscular fat, and metabolic risk factors in obese women. Diabetes Care. 2002;25:431–8.
Carrodeguas L, Kaidar-Person O, Szomstein S, Antozzi P, Rosenthal R. Preoperative thiamine deficiency in obese population undergoing laparoscopic bariatric surgery. Surg Obes Relat Dis. 2005;1:517–22.
Aasheim ET. Wernicke encephalopathy after bariatric surgery: a systematic review. Ann Surg. 2008;248:714–20.
WHO. Thiamine deficiency and its prevention and control in major emergencies [online]; 1999. http://whqlibdoc.who.int/hq/1999/WHO_NHD_99.13.pdf
Sriram K, Manzanares W, Joseph K. Thiamine in nutrition therapy. Nutr Clin Pract. 2012;27:41–50.
Kopelman MD, Thomson AD, Guerrini I, Marshal EJ. The Korsakoff syndrome: clinical aspects, psychology and treatment. Alcohol Alcohol. 2009;44:148–54.
Blume CA, Boni CC, Casagrande DS, Rizzolli J, Padoin AV, Mottin CC. Nutritional profile of patients before and after Roux-en-Y gastric bypass: 3-year follow-up. Obes Surg. 2012;22:1676–85.
Long AN, Atwell CL, Yoo W, Solomon SS. Vitamin B(12) deficiency associated with concomitant metformin and proton pump inhibitor use. Diabetes Care. 2012;35:e84.
Dalcanale L, Oliveira CP, Fainthuch J, et al. Long-term nutritional outcome after gastric bypass. Obes Surg. 2010;20:181–7.
Lachner C, Steinle NI, Regenild WT. The neuropsychiatry of vitamin B12 deficiency in elderly patients. J Neuropsychiatry Clin Neurosci. 2012;24:5–115.
Daulatabad D, Singal A, Grover C, Chhillar N. Prospective analytical controlled study evaluating serum biotin, vitamin B12, and folic acid in patients with premature canities. Int J Trichology. 2017;9:19–24.
Sharma N, Dogra D. Association of epidemiological and biochemical factors with premature graying of hair: a case-control study. Int J Trichology. 2018;10:211–7.
Said HM. Intestinal absorption of water-soluble vitamins in health and disease. Biochem J. 2011;437:357–72.
Mallory GN, Macgregor AM. Folate status following gastric bypass surgery (the great folate mystery). Obes Surg. 1991;1:69–72.
Shane B, Stokstad EL. Vitamin B12-folate interrelationships. Annu Rev Nutr. 1985;5:115–41.
von Drygalski A, Andris DA. Anemia after surgery: more than just iron deficiency. Nutr Clin Pract. 2009;234:217–26.
Hansen EP, Metzsche C, Henningsen E, Toft P. Severe scurvy after gastric bypass surgery and a poor postoperative diet. J Clin Med Res. 2012;4:135–7.
Simmons M. Modern-day scurvy: a case following gastric bypass. Bariatric Nurs Surg Patient Care. 2009;4:139–44.
Grethen E, McClintok R, Gupta CE, et al. Vitamin D and hyperparathyroidism in obesity. J Clin Endocrinol Metab. 2011;96:1320–6.
Youssef Y, Richards WO, Sekhar N, et al. Risk of secondary hyperparathyroidism after laparoscopic gastric bypass surgery in obese women. Surg Endosc. 2007;21:1393–6.
Ross AC, Manson JE, Abrams SA, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endorcinol Metab. 2011;96:53–8.
Hewitt S, Sovik TT, Aasheim ET, et al. Secondary hyperparathyroidism, vitamin D sufficiency, and serum calcium 5 years after gastric bypass and duodenal switch. Obes Surg. 2013;23:384–90.
Pereira SE, Saboya CJ, Saunders C, Ramalho A. Serum levels and liver store of retinol and their association with night blindness in individuals with class III obesity. Obes Surg. 2012;22:602–8.
Aills L, Blankenship J, Buffington C, Furtado M, Prrott J. ASMBS allied health nutritional guidelines for the surgical weight patient. Surg Obes Relat Dis. 2008;4:S73–108.
Slater GH, Ren CJ, Siegel N, et al. Serum fat-soluble vitamin deficiency and abnormal calcium metabolism after malabsorptive bariatric surgery. J Gastrointest Surg. 2004;8:48–55.
Strople J, Lovell G, Heubi J. Prevalence of subclinical vitamin K deficiency in cholestatic liver disease. J Pediatr Gastroenterol Nutr. 2009;49:78–84.
Ducros V, Pollicand M, Laporte F, Favier A. Quantitative determination of plasma vitamin K1 by high-performance liquid chromatography coupled to isotope dilution tandem mass spectrometry. Anal Biochem. 2010;401:7–14.
Watras MM, Patel JP, Arya R. Traditional anticoagulants and hair loss: a role for direct oral anticoagulants? A review of the literature. Drugs Real World Outcomes. 2016;3:1–6.
Song A, Fernstrom MH. Nutritional and psychological considerations after bariatric surgery. Aesthet Surg J. 2008;28:195–9.
Heber D, Greenway FL, Kaplan LM, Livingston E, Salvador J, Still C. Endocrine and nutritional management of the post-bariatric surgery patient: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2010;95:4823–43.
Castiglioni S, Cazzaniga A, Albisetti W, Maier JA. Magnesium and osteoporosis: current state of knowledge and future research directions. Nutrients. 2013;5:3022–33.
Corica F, Allegra A, Ientile R, Buemi M. Magnesium concentrations in plasma, erythrocytes, and platelets in hypertensive and normotensive obese patients. Am J Hypertens. 1997;10:1311–3.
Luk CP, Parsons R, Lee YP, Hughes JD. Proton pump inhibitor-associated hypomagnesemia: what do FDA data tell us? Ann Pharmacother. 2013;47:773–80.
Walker AF, Marakis G, Christie S, Byng M. Mg citrate found more bioavailable than other Mg preparations in a randomised, double-blind study. Magnes Res. 2003;16:183–91.
Ganzoni AM. Intravenous iron-dextran: therapeutic and experimental possibilities. Schweiz Med Wochenschr. 1970;100:301–3.
Mechanick JI, Youdim A, Jones DB, et al. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient—2013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society and American Society of Metabolic & Bariatric Surger. Obesity (Silver Spring). 2013;21(Suppl. 1):S1–27.
Shahidzadeh R, Sridhar S. Profound copper deficiency in a patient with gastric bypass. Am J Gastroenterol. 2008;103:2660–2.
Franko DL, et al. A longitudinal investigation of mortality in anorexia nervosa and bulimia nervosa. Am J Psychiatry. 2013;2170:917–25.
Vaughan ED Jr, Sawyers JL, Scott HW Jr. The Rapunzel syndrome. An unusual complication of intestinal bezoar. Surgery. 1968;63:339–43.
Hergüner S, Ozyildirim I, Tanidir C. Is Pica an eating disorder or an obsessive-compulsive spectrum disorder? Prog Neuropsychopharmacol Biol Psychiatry. 2008;32:2010–1.
Miao D, Young SL, Golden CD. A meta-analysis of pica and micronutrient status. Am J Hum Biol. 2015;27:84–93.
McGehee FT Jr, Buchanan GR. Trichophagia and trichobezoar: etiologic role of iron deficiency. J Pediatr. 1980;97:946–8.
Cannalire G, Conti L, Celoni M, Grassi C, Cella A, Bensi G, Capelli P, Biasucci G. Rapunzel syndrome: an infrequent cause of severe iron deficiency anemia and abdominal pain presenting to the pediatric emergency department. BMC Pediatr. 2018;18:125.
Hadnagy C, Binder P, Grauzer J, Szöcs K. Trichophagia treated successfully by intravenous iron injections [Article in Hungarian]. Orv Hetil. 1991;132:35–6.
Hadnagy C, Grauzer SJ, Binder P, Szöcs K. Iron therapy in mental aberrations (pica) in childhood [Article in German]. Kinderarztl Prax. 1991;59:126–8.
Grant JE, Odlaug BL, Kim SW. N-acetylcysteine, a glutamate modulator, in the treatment of trichotillomania: a double-blind, placebo-controlled study. Arch Gen Psychiatry. 2009;66:756–63.
Bloch MH, Panza KE, Grant JE, Pittenger C, Leckman JF. N-acetylcysteine in the treatment of pediatric trichotillomania: a randomized, double-blind, placebo-controlled add-on trial. J Am Acad Child Adolesc Psychiatry. 2013;52:231–40.
Grant JE, Odlaug BL, Chamberlain SR, Kim SW. Dronabinol, a cannabinoid agonist, reduces hair pulling in trichotillomania: a pilot study. Psychopharmacology (Berl). 2011;218:493–502.
Culbert KM, Racine SE, Klump KL. Research review: what have we learned about the causes of eating disorders—a synthesis of sociocultural, psychological and biological research. J Child Psychol Psychiatry. 2015;56:1141–64.
Matthews-Ewald MR, Zullig KH, Ward RM. Sexual orientation and disordered eating behaviors among self-identified male and female college students. Eat Behav. 2014;15:441–4.
Strumia R. Skin signs in anorexia nervosa. Dermatoendocrinol. 2009;1:268–70.
Hediger C, Rost B, Itin P. Cutaneous manifestations in anorexia nervosa. Schweiz Med Wochenschr. 2000;130:565–75.
Zucker N, Von Holle A, Thornton LM, Strober M, Plotnicov K, Klump KL, Brandt H, Crawford S, Crow S, Fichter MM, Halmi KA, Johnson C, Kaplan AS, Keel P, LaVia M, Mitchell JE, Rotondo A, Woodside DB, Berrettini WH, Kaye WH, Bulik CM. The significance of repetitive hair-pulling behaviors in eating disorders. J Clin Psychol. 2011;67:391–403.
Grillo E, Vano-Galvan S, Diaz-Ley B, Jaén P. Patchy hair loss on the pubis—a case study. Aust Fam Physician. 2013;42:487–9.
Achamrah N, Coëffier M, Rimbert A, Charles J, Folope V, Petit A, Déchelotte P, Grigioni S. Micronutrient status in 153 patients with anorexia nervosa. Nutrients. 2017;9:225.
Shay NF, Mangian HF. Neurobiology of zinc-influenced eating behavior. J Nutr. 2000;130:1493S–9S.
Hambidge KM, Hambidge C, Jacobs M, Baum JD. Low levels of zinc in hair, anorexia, poor growth, and hypogeusia in children. Pediatr Res. 1972;6:868–74.
Lask B, Fosson A, Rolfe U, Thomas S. Zinc deficiency and childhood-onset anorexia nervosa. J Clin Psychiatry. 1993;54:63–6.
Yamaguchi H, Arita Y, Hara Y, Kimura T, Nawata H. Anorexia nervosa responding to zinc supplementation: a case report. Gastroenterol Jpn. 1992;27:554–8.
Birmingham CL, Gritzner S. How does zinc supplementation benefit anorexia nervosa? Eat Weight Disord. 2006;11:e109–11.
Seeger G, Braus DF, Ruf M, Goldberger U, Schmidt MH. Body image distortion reveals amygdala activation in patients with anorexia nervosa—a functional magnetic resonance imaging study. Neurosci Lett. 2002;326:25–8.
Takano A, Shiga T, Kitagawa N, Koyama T, Katoh C, Tsukamoto E, Tamaki N. Abnormal neuronal network in anorexia nervosa studied with I-123-IMP SPECT. Psychiatry Res. 2001;107:45–50.
O’Connor G, Nicholls D. Refeeding hypophosphatemia in adolescents with anorexia nervosa: a systematic review. Nutr Clin Pract. 2013;28:358–64.
Kaye W. Neurobiology of anorexia and bulimia nervosa. Physiol Behav. 2008;94:121–35.
Dietary Guidelines for Americans 2005. health.gov. 2005. Archived from the original on 1 July 2007. Dietary Guidelines.
Young adult drinking. Alcohol alert (68). April 2006. Archived from the original on 13 February 2013. Accessed 18 February 2013.
Ryle PR, Thomson AD. Nutrition and vitamins in alcoholism. Contemp Issues Clin Biochem. 1984;1:188–224.
Sanvisens A, Zuluaga P, Pineda M, Fuster D, Bolao F, Juncà J, Tor J, Muga R. Folate deficiency in patients seeking treatment of alcohol use disorder. Drug Alcohol Depend. 2017;180:417–22.
Narasimha VL, Ganesh S, Reddy S, Shukla L, Mukherjee D, Kandasamy A, Chand PK, Benegal V, Murthy P. Pellagra and alcohol dependence syndrome: findings from a tertiary care addiction treatment centre in India. Alcohol Alcohol. 2019;54:148–51.
Shaikh H, Faisal MS, Mewawalla P. Vitamin C deficiency: rare cause of severe anemia with hemolysis. Int J Hematol. 2019;109:618–62.
Kopecký A, Benda F, Němčanský J. Xerosis in patient with vitamin A deficiency—a case report. Cesk Slov Oftalmol. 2018;73:222–4.
Sharain K, May AM, Gersh BJ. Chronic alcoholism and the danger of profound hypomagnesemia. Am J Med. 2015;128:e17–8.
Anty R, Canivet CM, Patouraux S, Ferrari-Panaia P, Saint-Paul MC, Huet PM, Lebeaupin C, Iannelli A, Gual P, Tran A. Severe vitamin D deficiency may be an additional cofactor for the occurrence of alcoholic steatohepatitis. Alcohol Clin Exp Res. 2015;39:1027–33.
Shahsavari D, Ahmed Z, Karikkineth A, Williams R, Zigel C. Zinc-deficiency acrodermatitis in a patient with chronic alcoholism and gastric bypass: a case report. J Community Hosp Intern Med Perspect. 2014;31:4.
Tanner AR, Bantock I, Hinks L, Lloyd B, Turner NR, Wright R. Depressed selenium and vitamin E levels in an alcoholic population. Possible relationship to hepatic injury through increased lipid peroxidation. Dig Dis Sci. 1986;31:1307–12.
Iber FL, Shamszad M, Miller PA, Jacob R. Vitamin K deficiency in chronic alcoholic males. Alcohol Clin Exp Res. 1986;10:679–81.
Shibazaki S, Uchiyama S, Tsuda K, Taniuchi N. Copper deficiency caused by excessive alcohol consumption. BMJ Case Rep. 2017;26:pii: bcr-2017-220921.
Bahmer FA, Bader M. Skin changes in chronic alcoholism with special reference to the zinc and biotin content of the serum [Article in German]. Z Hautkr. 1987;62:691–5.
Bader U, Hafner J, Burg G. Erythroderma and alcohol abuse [Article in German]. Schweiz Med Wochenschr. 1999;129:508–13.
Rao GS. Cutaneous changes in chronic alcoholics. Indian J Dermatol Venereol Leprol. 2004;70:79–8.
Kostović K, Lipozencić J. Skin diseases in alcoholics. Acta Dermatovenerol Croat. 2004;12:181–90.
Christenson B. Queen of Punt. Clin Infect Dis. 2006;42:1344–5.
Biondi A, Freni F, Carelli C, Moretti M, Morini L. Ethyl glucuronide hair testing: a review. Forensic Sci Int. 2019;300:106–19.
Morini L, Sempio C, Moretti M. Ethyl glucuronide in hair (hEtG) after exposure to alcohol-based perfumes. Curr Pharm Biotechnol. 2018;19:175–9.
Luginbühl M, Bekaert B, Suesse S, Weinmann W. Detox shampoos for EtG and FAEE in hair—results from in vitro experiments. Drug Test Anal. 2019;11:870–7.
Hayflick L, Moorhead PS. The serial cultivation of human diploid cell strains. Exp Cell Res. 1961;25:585–621.
Deutz NE, Bauer JM, Barazzoni R, Biolo G, Boirie Y, Bosy-Westphal A, Cederholm T, Cruz-Jentoft A, Krznariç Z, Nair KS, Singer P, Teta D, Tipton K, Calder PC. Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN Expert Group. Clin Nutr. 2014;33:929–36.
Food and Nutrition Board, Institute of Medicine. Dietary reference intakes for thiamin, riboflavin, niacin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin, and choline. Washington DC: National Academics Press; 1998.
Norman AW, Bouillon R. Vitamin D nutritional policy needs a vision for the future. Exp Biol Med (Maywood). 2010;235:1034–45.
Johnson KA, Bernard MA, Funderberg K. Vitamin nutrition in older adults. Clin Geriatr Med. 2002;18:773–99.
Wolff JL, Starfield B, Anderson G. Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch Intern Med. 2002;162:2269–76.
Diekmann R, Winning K, Uter W, Kaiser MJ, Sieber CC, Volkert D, Bauer JM. Screening for malnutrition among nursing home residents—a comparative analysis of the mini nutritional assessment, the nutritional risk screen, and the malnutrition universal screening tool. J Nutr Health Aging. 2013;17:326–31.
Valderas JM, Starfield B, Sibbald B, Salisbury C, Roland M. Defining comorbidity: implications for understanding health and health services. Ann Fam Med. 2009;7:357–63.
National Center for Health Statistics. Health, United States, 2014: with special feature of adults aged 55-64. Hyattsville, MD: U.S. Government Printing Office; 2015.
Pinkus H. Alopecia: clinicopathologic correlations. Int J Dermatol. 1980;19:245–53.
Ebling FJ. Age changes in cutaneous appendages. J Appl Cosmetol. 1985;3:243–50.
Kligman AM. The comparative histopathology of male-pattern baldness and senescent baldness. Clin Dermatol. 1988;6:108–18.
Trüeb RM, Tobin DH, editors. Aging hair. Berlin Heidelberg: Springer; 2010.
Tobin DJ, Paus R. Graying: gerontobiology of the hair follicle pigmentary unit. Exp Gerontol. 2001;36:29–54.
Pandhi D, Khanna D. Premature graying of hair. Indian J Dermatol Venereol Leprol. 2013;79:641–53.
Mosley JG, Gibbs CC. Premature grey hair and hair loss among smokers: a new opportunity for health education? BMJ. 1996;313:1616.
Commo S, Gaillard O, Bernard BA. Human hair greying is linked to a specific depletion of hair follicle melanocytes affecting both the bulb and the outer root sheath. Br J Dermatol. 2004;150:435–43.
Tobin DJ, Paus R. Graying: gerontobiology of the hair follicle pigmentary unit. Exp Gerontol. 2001;36:29–54.
Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol. 1956;11:298–300.
Arck PC, Overall R, Spatz K, et al. Towards a “free radical theory of graying”: melanocyte apoptosis in the aging human hair follicle is an indicator of oxidative stress induced tissue damage. FASEB J. 2006;20:1567–9.
Wood JM, Decker H, Hartmann H, et al. Senile hair greying: H2O2-mediated oxidative stress affects human hair colour by blunting methionine sulfoxide repair. FASEB J. 2009;23:2065–75.
Nishimura EK, Jordan SA, Oshima H, et al. Dominant role of the niche in melanocyte stem-cell fate determination. Nature. 2002;416:854–60.
Nishimura EK, Granter SR, Fisher DE. Mechanisms of hair graying: incomplete melanocyte stem cell maintenance in the niche. Science. 2005;307:720–4.
Hollfelder B, Blankenburg G, Wolfram LJ, Höcker H. Chemical and physical properties of pigmented and non-pigmented hair (‘grey hair’). Int J Cosmet Sci. 1995;17:87–9.
Jeon SY, Pi LQ, Lee WS. Comparison of hair shaft damage after UVA and UVB irradiation. J Cosmet Sci. 2008;59:151–6.
Otsuka H, Nemoto T. Study on Japanese hair. Koshkaischi. 1988;12:192–7.
Robbins C, Mirmirani P, Messenger AG, Birch MP, Youngquist RS, Tamura M, Filloon T, Luo F, Dawson TLJ. What women want—quantifying the perception of hair amount: an analysis of hair diameter and density changes with age in Caucasian women. Br J Dermatol. 2012;167:324–32.
Birch MP, Messenger JF, Messenger AG. Hair density, hair diameter and the prevalence of female pattern hair loss. Br J Dermatol. 2001;144:297–304.
Otsuka H, Nemoto T. Study on Japanese hair. Koshkaischi. 1988;12:192–7.
Courtois M, Loussouarn G, Hourseau C, Grollier JF. Aging and hair cycles. Br J Dermatol. 1995;132:86–93.
Price VH, Sawaya ME, Headington JT et al. Histology and hormonal activity in senescent thinning in men. Present at SID, Annual Meeting, Washington DC; 2001
Sperling LC. Senescent balding (“senile alopecia”). In: Sperling LC, editor. An atlas of hair pathology with clinical correlations. New York: Parthenon Publishing; 2003. p. 35–6.
Sinclair R, Chapman A, Magee J. The lack of significant changes in scalp hair follicle density with advancing age. Br J Dermatol. 2005;152:646–9.
Whiting DA. How real is senescent alopecia? A histopathologic approach. Clin Dermatol. 2011;29:49–53.
Karnik P, Shah S, Dvorkin-Wininger Y, et al. Microarray analysis of androgenetic and senescent alopecia: comparison of gene expression shows two distinct profiles. J Dermatol Sci. 2013;72:183–6.
Nagase S, Tsuchiya M, Matsui T, Shibuichi S, Tsujimura H, Masukawa Y, Satoh N, Itou T, Koike K, Tsujii K. Characterization of curved hair of Japanese women with reference to internal structures and amino acid composition. J Cosmet Sci. 2008;59:317–32.
Nicolaides N, Rothman S. Studies on the chemical composition of human hair fat. II. The overall composition with regard to age, sex and race. J Invest Dermatol. 1953;21:9–14.
Matsumura H, Mohri Y, Binh NT, Morinaga H, Fukuda M, Ito M, Kurata S, Hoeijmakers J, Nishimura EK. Hair follicle aging is driven by transepidermal elimination of stem cells via COL17A1 proteolysis. Science. 2016;351(6273):aad4395.
Inomata K, Aoto T, Binh NT, Okamoto N, Tanimura S, Wakayama T, Iseki S, Hara E, Masunaga T, Shimizu H, Nishimura EK. Genotoxic stress abrogates renewal of melanocyte stem cells by triggering their differentiation. Cell. 2009;137:1088–99.
Liu N, Matsumura H, Kato T, Ichinose S, Takada A, Namiki T, Asakawa K, Morinaga H, Mohri Y, De Arcangelis A, Geroges-Labouesse E, Nanba D, Nishimura EK. Stem cell competition orchestrates skin homeostasis and ageing. Nature. 2019;568:344–50.
Floeth M, Fiedorowicz J, Schäcke H, Hammami-Hausli N, Owaribe K, Trüeb RM, Bruckner-Tuderman L. Novel homozygous and compound heterozygous COL17A1 mutations associated with junctional epidermolysis bullosa. J Invest Dermatol. 1998;111:528–33.
Hintner H, Wolff K. Generalized atrophic benign epidermolysis bullosa. Arch Dermatol. 1982;118:375–84.
Natsuga K, Watanabe M, Nishie W, Shimizu H. Life before and beyond blistering: the role of collagen XVII in epidermal physiology. Exp Dermatol. 2019;28:1135–41.
Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature. 1990;345:458–60.
Rudolph KL, Chang S, Lee HW, et al. Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell. 1999;96:701–12.
Kao SH, Liu CS, Wang SY, Wei YH. Ageing-associated large-scale deletions of mitochondrial DNA in human hair follicles. Biochem Mol Biol Int. 1997;42:285–98.
Nakauchi Y, Kumon Y, Yamasaki H, et al. Scalp hair loss caused by octreotide in a patient with acromegaly: a case report. Endocr J. 1995;42(3):385–9.
Yamada S, Fukuhara N, Nishioka H, et al. Scalp hair loss after transsphenoidal adenomectomy in patients with acromegaly. Clin Endocrinol (Oxf). 2013;79:386–93.
Lurie R, Ben-Amitai D, Laron Z. Laron syndrome (primary growth hormone insensitivity): a unique model to explore the effect of insulin-like growth factor 1 deficiency on human hair. Dermatolog. 2004;208:314–8.
Rundegren J. Pattern alopecia: what clinical features determine the response to topical minoxidil treatment? (IHRS 2004 abstract B2.4). JDDG. 2004;2:500.
CG 210 hair & scalp lotion. Product monograph. Legacy Healthcare.
Trüeb RM. Molecular mechanisms of androgenetic alopecia. Exp Gerontol. 2002;37:981–90.
Katoulis AC, Liakou AI, Alevizou A, Bonovas S, Bozi E, Kontogiorgi D, Rigopoulos D. Efficacy and safety of a topical botanical in female androgenetic alopecia: a randomized, single-blinded, vehicle-controlled study. Skin Appendage Disord. 2018;4:160–5.
McMichael A, Pham A, von Grote E, Meckfessel MH. Efficacy and safety of minoxidil 2% solution in combination with a botanical hair solution in women with female pattern hair loss/androgenic alopecia. J Drugs Dermatol. 2016;15:398–404.
Keaney TC, Pham H, von Grote E, Meckfessel MH. Efficacy and safety of minoxidil 5% foam in combination with a botanical hair solution in men with androgenic alopecia. J Drugs Dermatol. 2016;15:406–12.
Takeda A, Sato A, Zhang L, Harti S, Cauwen-bergh G, et al. CG210 enables finasteride 1 mg users to further improve hair pattern: a randomized, double-blind, placebo-controlled pilot study. Hair Ther Transplant. 2013;3:107.
Cucé LC, Rodrigues CJ, Patriota RCR. Cellium® GC: evaluation of a new natural active ingredient in 210 mg/mL topical solution, through scalp biopsy. Surg Cosmet Dermatol. 2011;3:123–8.
Blatt T, Littarru GP. Biochemical rationale and experimental data on the antiaging properties of CoQ(10) at skin level. Biofactors. 2011;37:381–5.
Giesen M, Welss T, Wiesche ES, et al. Coenzyme Q10 has anti-aging effects on human hair. Int J Cosmet Sci. 2009;31:154–5.
Giesen M, Gruedl S, Holtkoetter O, Fuhrmann G, Koerner A, Petersohn D. Ageing processes influence keratin and KAP expression in human hair follicles. Exp Dermatol. 2011;20:759–61.
Choi FD, Sung CT, Juhasz ML, Mesinkovsk NA. Oral collagen supplementation: a systematic review of dermatological applications. J Drugs Dermatol. 2019;18:9–16.
Arthur ST, Noone JM, Van Doren BA, Roy D, Blanchette CM. One-year prevalence, comorbidities and cost of cachexia-related inpatient admissions in the USA. Drugs Context. 2014;3:212,265.
von Haehling S. Anker SD. Prevalence, incidence and clinical impact of cachexia: facts and numbers-update 2014. J Cachexia Sarcopenia Muscle. 2014;5:261–3.
Academy of Nutrition and Dietetics. Nutrition care manual. Chicago, IL: Academy of Nutrition and Dietetics; 2015.
Cathcart P, Craddock C, Stebbing J. Fasting: starving cancer. Lancet Oncol. 2017;18(4):431.
Saleh AD, Simone BA, Palazzo J, et al. Caloric restriction augments radiation efficacy in breast cancer. Cell Cycle. 2013;12:1955–63.
Thissen JP, Ketelslegers JM, Underwood LE. Nutritional regulation of the insulin-like growth factors. Endocr Rev. 1994;15:80–101.
Simone BA, Champ CE, Rosenberg AL, Berger AC, Monti DA, Dicker AP, Simone NL. Selectively starving cancer cells through dietary manipulation: methods and clinical implications. Future Oncol. 2013;9:959–76.
Blackburn GL, Bistrian BR, Hoag C. Hair loss with rapid weight loss. Arch Dermatol. 1977;113(2):234.
Zick SM, Snyder D, Abrams DI. Pros and cons of dietary strategies popular among cancer patients. Oncology (Williston Park). 2018;32:542–7.
Dinu M, Abbate R, Gensini GF, et al. Vegetarian, vegan diets and multiple health outcomes: a systematic review with meta-analysis of observational studies. Crit Rev Food Sci Nutr. 2017;57:3640–9.
Gröber U, Holzhauer P, Kisters K, Holick MF, Adamietz IA. Micronutrients in oncological intervention. Nutrients. 2016;8:163.
Micke O, Bruns F, Glatzel M, Schönekaes K, Micke P, Mücke R. Predictive factors for the use of complementary and alternative medicine (CAM) in radiation oncology. Eur J Integr Med. 2009;1:22–30.
Lawenda BD, Kelly KM, Lasas EJ, et al. Should supplemental antioxidant administration be avoided during chemotherapy and radiotherapy? J Natl Cancer Inst. 2008;100:773–83.
Gröber U, Mücke R, Adamietz IA, Holzhauer P, Kisters K, Büntzel J, Micke O. Komplementärer Einsatz von Antioxidanzien aund Mikronährstoffen in der Onkologie – Update 2013. Der Onkol. 2013;19:136–43.
Moss RW. Should patients undergoing chemotherapy and radiotherapy be prescribed antioxidants? Integr Cancer Ther. 2006;5:63–82.
Tong H, Isenring E, Yates P. The prevalence of nutrition impact symptoms and their relationship to quality of life and clinical outcomes in medical oncology patients. Support Care Cancer. 2009;17:83–90.
Fearon KC, Voss AC, Hustend DS. Definition of cancer cachexia: effect of weight loss reduced food intake and systemic inflammation on functional status and prognosis. Am J Clin Nutr. 2006;83:1345–50.
Bozzetti F. SCRINIO Working Group Screening the nutritional status in oncology: a preliminary report on 1000 outpatients. Support Care Cancer. 2009;17:279–84.
Harvie M. Nutritional supplements and cancer: potential benefits and proven harms. Am Soc Clin Oncol Educ Book. 2014:e478–86.
Trüeb RM, Jolliffe VML, Régnier AF, et al. Precision medicine and the practice of trichiatry: adapting the concept. Skin Appendage Disord. 2019;5:338–43.
McGarvey EL, Baum LD, Pinkerton RC, et al. Psychological sequelae and alopecia among women with cancer. Cancer Pract. 2001;9:283–9.
Trüeb RM. Chemotherapy-induced anagen effluvium: diffuse or patterned? Dermatology. 2007;215:1–2.
Trüeb RM. Chemotherapy-induced alopecia. Semin Cutan Med Surg. 2009;28:11–4.
Baker B, Wilson C, Davis A, et al. Busulphan/cyclophosphamide conditioning for bone marrow transplantation may lead to failure of hair regrowth. Bone Marrow Transplant. 1991;7:43–7.
Vowels M, Chan LL, Giri N, et al. Factors affecting hair regrowth after bone marrow transplantation. Bone Marrow Transplant. 1993;12:347–50.
Kluger N, Jacot W, Frouin E, et al. Permanent scalp alopecia related to breast cancer chemotherapy by sequential fluorouracil/epirubicin/cyclophosphamide (FEC) and docetaxel: a prospective study of 20 patients. Ann Oncol. 2012;23:2879–84.
Miteva M, Misciali C, Fanti PA, Vincenzi C, Romanelli P, Tosti A. Permanent alopecia after systemic chemotherapy: a clinicopathological study of 10 cases. Am J Dermatopathol. 2011;33:345–50.
Betticher DC, Delmore G, Breitenstein U, et al. Efficacy and tolerability of two scalp cooling systems for the prevention of alopecia associated with docetaxel treatment. Support Care Cancer. 2013;21:2565–73.
Plonka PM, Handjiski B, Popik M, Michalczyk D, Paus R. Zinc as an ambivalent but potent modulator of murine hair growth in vivo preliminary observations. Exp Dermatol. 2005;14:844–53.
Tsuruki T, Takahata K, Yoshikawa M. Anti-alopecia mechanisms of soymetide-4, an immunostimulating peptide derived from soy beta-conglycinin. Peptides. 2005;26:707–11.
Sieja K, Taleruyk M. Selenium as an element in the treatment of ovarian cancer in women (n = 31) receiving chemotherapy. Gynecol Oncol. 2004;93:320–7.
Wang J, Lu Z, Au JLS. Protection against chemotherapy-induced alopecia. Pharm Res. 2006;23:2505–14.
Tran D, Sinclair RD, Schwarer AP, et al. Permanent alopecia following chemotherapy and bone marrow transplantation. Austral J Dermatol. 2000;41:106–8.
Freites-Martinez A, Shapiro J, Chan D, Fornier M, Modi S, Gajria D, Dusza S, Goldfarb S, Lacouture ME. Endocrine therapy-induced alopecia in patients with breast cancer. JAMA Dermatol. 2018;154:670–5.
Kluger N, Jacot W, Frouin E, et al. Permanent scalp alopecia related to breast cancer chemotherapy by sequential fluorouracil/epirubicin/cyclophosphamide (FEC) and docetaxel: a prospective study of 20 patients. Ann Oncol. 2012;23:2879–84.
Trüeb RM. Minoxidil for endocrine therapy-induced alopecia in women with breast cancer-saint Agatha’s Blessing? JAMA Dermatol. 2018;154:656–8.
Mundstedt K, Manthey N, Sachsse S, et al. Changes in self-concept and body image during alopecia induced cancer chemotherapy. Support Care Cancer. 1997;5:139–43.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Trüeb, R.M. (2020). Nutritional Disorders of the Hair and Their Management. In: Nutrition for Healthy Hair. Springer, Cham. https://doi.org/10.1007/978-3-030-59920-1_5
Download citation
DOI: https://doi.org/10.1007/978-3-030-59920-1_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-59919-5
Online ISBN: 978-3-030-59920-1
eBook Packages: MedicineMedicine (R0)